Skip to content
Psychedelics have established themselves as a game changer in the drug development space in recent years. And it is not just scientists who are […]
Psychedelics ‘do things in the brain that nothing else does’ Read More »
“We all just went through a pandemic together,” began Phyllis Arthur, Vice President of Infectious Disease & Emerging Science Policy at the Biotechnology Innovation
How can we increase routine adult vaccination? Read More »
The disease burden of RSV has been a tough problem for biotech R&D to solve for over 60 years. However, within the last year,
We’re conquering RSV for the young and old – but more innovation is needed Read More »
Cancer is less the death sentence that it used to be. That does not mean that cancer treatment can’t be profoundly life-altering or that
NIH Innovation Zone: Meet Privo Technologies Read More »
Patient stories and relationships are at the heart of state advocacy. “A lot of policymakers are just not aware of what our companies are,
How to build a state or regional advocacy arm Read More »
COVID was unequivocal in how it shined a light onto profound global health inequity and access issues. And nowhere was that more clear than
Vaccine manufacturing in Africa: challenges and opportunities Read More »
“The policy environment is something that a lot of people seem to think is this separate, strange thing that has very little to do
Enhancing public health preparedness through policy and partnership Read More »
Pfizer’s ABRYSVO vaccine for respiratory syncytial virus (RSV) received U.S. Food and Drug Administration (FDA) approval for use in adults over age 60 on
FDA approves Pfizer’s RSV vaccine for adults over age 60 Read More »
On May 23, the House Committee on Oversight and Accountability sought to answer this question: are PBMs (pharmacy benefit managers) working in the interest
Are PBMs working in the interest of health care – or themselves? Read More »
Pharmacy benefit managers (PBMs) and hospitals using the 340B program were in the crosshairs on May 17 as the House Energy & Commerce Health
E&C Health Subcommittee advances bills to bring transparency to PBMs and 340B Read More »
